Q2 2023 Holdings
Filed 2023-08-10 | 190 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Broadcom Inc(AVGO) | COM | 11135F101 | $11.0M | 12,651 | 0.8% |
| Chevron Corp New(CVX) | COM | 166764100 | $12.8M | 81,350 | 0.9% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $12.8M | 325,548 | 0.9% |
| Microsoft Corp(MSFT) | COM | 594918104 | $12.8M | 37,694 | 0.9% |
| Symbotic Inc(SYM) | CLASS A COM | 87151X101 | $13.9M | 325,321 | 1.0% |
| Fluence Energy Inc(FLNC) | COM CL A | 34379V103 | $14.1M | 530,662 | 1.0% |
| TFI Intl Inc(TFII) | COM | 87241L109 | $14.9M | 130,996 | 1.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.2M | 170,609 | 1.0% |
| Championx Corporation(APY1EUR) | COM | 15872M104 | $15.7M | 505,756 | 1.1% |
| Iridium Communications Inc(IRDM) | COM | 46269C102 | $16.1M | 259,622 | 1.1% |
| Celsius Hldgs Inc(CELH) | COM NEW | 15118V207 | $16.5M | 110,646 | 1.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $17.2M | 90,351 | 1.2% |
| Caci Intl Inc(CACI) | CL A | 127190304 | $17.3M | 50,791 | 1.2% |
| Exxon Mobil Corp(XOM) | COM | 30231G102 | $17.5M | 163,000 | 1.2% |
| Lattice Semiconductor Corp(LSCC) | COM | 518415104 | $18.6M | 193,348 | 1.3% |
| Dice Therapeutics Inc | COM | 23345J104 | $19.3M | 416,151 | 1.3% |
| Monolithic PWR SYS Inc(MPWR) | COM | 609839105 | $19.5M | 36,047 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $22.3M | 682,867 | 1.5% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $22.6M | 269,769 | 1.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $22.8M | 2,265,323 | 1.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $23.0M | 460,164 | 1.6% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $23.1M | 1,224,127 | 1.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $23.7M | 915,119 | 1.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $24.6M | 1,163,355 | 1.7% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $26.7M | 2,237,111 | 1.8% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $28.2M | 80,116 | 1.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $28.3M | 244,934 | 1.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $28.4M | 394,884 | 1.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $30.5M | 791,118 | 2.1% |
| Transmedics Group Inc(TMDX) | COM | 89377M109 | $30.9M | 367,631 | 2.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $31.6M | 499,503 | 2.2% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $32.3M | 112,999 | 2.2% |
| Karuna Therapeutics Inc | COM | 48576A100 | $33.8M | 155,930 | 2.3% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $35.7M | 928,637 | 2.4% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $36.8M | 536,015 | 2.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $37.2M | 95,414 | 2.5% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $37.4M | 115,187 | 2.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $37.8M | 414,419 | 2.6% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $40.9M | 593,167 | 2.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $44.0M | 374,951 | 3.0% |